Case 7: MS, Parkinsons, spinal cord compression Flashcards
MS: managing symptoms
- Fatigue:can be overwhelming and disabling: Cooling, Pacing activities, CBT, Mindfullness, Amantadine
- Mood:Depression is common in MS: CBT, SSRIs, Duloxetine
- Cognition:Cognition deteriorates as disease becomes advanced: Social support, rule out sleep issues/pain/depression
- Spasticity:This can lead to pain and discomfort: Physiotherapy, Baclofen, BoTox
- Pain:Typically neuropathic type pain: CBT, Amitriptyline, Gabapentin, Pregabalin
- Neurogenic bladder issues:Urinary frequency, urgency, nocturia. Frequent UTIs: Fluid intake control, regimented toilet regime, Oxybutinin, BoTox injection, intermittent self-catherterisation
- Constipation:Difficulty opening bowels, or mobilising to toilet: Good diet and fluid, regular laxatives, bowel care, assistedevacuation, good hygiene
Parkinson’s symptoms: motor
- Slowness
- Gait alteration (arm-swing less on affected side, shuffle, reduced stride length)
- Loss of dexterity
- Resting tremor ( pill rolling coarse, 4Hz, re-emergent)
- Postural alteration (antecollis, Pisa- lean to one side, camptocormia- bent double).Reduced arm swing and hunched appearance
- Falls and imbalance
Parkinson’s symptoms: non-motor
- Depression/anxiety
- Constipation, urinary symptoms, postural hypotension
- Shoulder pain
- REM behaviour disorder: move a lot in sleep, can occur years before motor symptoms
- Restless leg syndrome/Periodic leg movement in sleep
- Hypersalivation
- Subjective memory issues
- Anosmia: often present years before diagnosis
- Parkinson’s Disease Dementia seen in patients with motor symptoms for 10+ years. Causes afluctuatingcognitive deficit, impaired visuospatial function and frequent visual hallucinations as well as memory problems.
Parkinson’s medication
- CDMT inhibitor: preserve levodopa and dopamine
- Levodopa: replaces dopamine
- Dopamine agonists i.e. ropinirole: mimic dopamine. Side effects lack of impulse control. Can be given by transdermal patch
- MAO-B inhibitors i.e. Rasigilline: preserve existing dopamine
- Non-oral: Apomorphine infusion (levodopa is continuously released under the skin) , deep brain stimulation, Duodopa (PEG tube which releases levodopa continuously- best for fluctuating symptoms), Cueing and physiotherapy
- Combine Levodopa with carbidopa pr benserazide creating co-careldopa and co-beneldopa
Names of Parkinson’s medications
- Levodopa (+ Carbidopa/Benserazide)= Madopar, Sinemet
- Dopamine Agonist= Rotigotine, Ropinirole, Pramipexole (given for restless leg)
- Stronger dopamine agonist: Apomorphine- given by SC infusion
- MAO-B inhibitors = Rasagiline, Seligiline
- COMT inhibitors= Entacapone, Epicapone
Cause of Parkinson’s
Caused by loss of dopaminergic neurones in the substantia nigra in the basal ganglia. The basal ganglia is essential for coordinating movement. Due to accumulation of alpha synuclein in the form of ‘lewy bodies.’
Braak stages in Parkinson’s
- Braak stage 1 and 2: autonomic and olfactory disturbances
- Braak stages 3 and 4: sleep and motor disturbances
- Braak stage 5 and 6: emotional and cognitive disturbances
Symptoms of Parkinson’s
- Bradykinesia- slow movement
- Tremor- rest, postural
- Rigiditity- cog wheeling, lead pipe
- Postural instability- late feature
- Early features- loss of sense of smell, REM sleep behaviour disorder, constipation, depression and anxiety
- Late complications- bladder and blood pressure problems, pyschosis and dementia
Differentials for Parkinson’s
- Essential tremor
- Drug induced parkinsonism
- Dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration
- Alzheimer’s and multiple cerebral infarctions
Clinical examination in Parkinson- gait
- Stooped posture
- Forward flexion of the trunk and the knees
- Arms flexed at the elbows and wrists
- Known as shuffling gait due to small and fast steps
- Difficulty initiating turning around
Clinical examination in Parkinson’s- tremor
- Resting tremor
- Pill rolling, looks like the patient is trying to roll a pill between their thumb and index finger
- 4-6Hz
- Asymmetrical, worse at rest
- Improves with movement
- No change with alcohol
UK Parkinsons disease society brain bank clinical diagnostic criteria
Step 1- diagnosis of Parkinsonian syndrome
- Bradykinesia
- At least one of muscle rigidity, resting tremor, postural instability
Step 2- exclusion criteria for Parkinson’s disease:
- History of strokes/ head injury/ encephalitis
- Oculogyric crisis
- Neuroleptic treatment at onset of symptoms
- Sustained remission
- Cerebrallar signs
- Cerebral tumour
Step 3- supportive positive criteria for Parkinson’s disease
What is the supportive positive criteria for Parkinsons
- Three or more are required alongside step one
- Unilateral onset
- Resting tremor present
- Disease is progressive
- Good response to levodopa
Parkinson’s- investigations
DAT scan- less dye is taken up. Reduced uptake in the substantia nigra, particularly in the posterior part of the putamen. Motor symptoms begin in stage 4
MRI/CT- to rule out other things
Bedside- physical examination, anosmia testing
Bloods
Management plan in Parkinsons
First line treatment- levodopa. Addition of a dopamine agonist/ MAO-B inhibitor as an adjunct if motor symptoms are not controlled
Supportive therapies- include physiotherapy/ occupational therapy/ speech and language therapy/ diet advice
Can give deep brain stimulation: surgical option, works best for dopamine responsive tremor
Levodopa
Usually combined with carbidopa to prolong action (peripheral inhibitor of dopamine metabolism). Side effects include dyskinesia when doses are high, impulsive behaviour, NV, loss of appetite, hypotension. Becomes less effective over time
Dyskinesia with levodopa
- Excessive motor activity when the dose is too high
- Dystonia - excessive muscle contraction leading to abnormal postures and movements
- Chorea - abnormal involuntary movements that are jerky and random
- Athetoid - involuntary twisting or writhing movements typically of the fingers / feet / hands
As the levodopa wears off
- Occurs as more dopaminergic cells die off- tend to be 5 years after treatment
- Delayed ‘on’ - where patients have to wait longer for dopamine levels to rise following their medication
- Wearing ‘off’ - where symptoms return earlier when the next dose is due
Dopamine agonists
- Stimulate dopamine receptors in the basal ganglia
- Side effects include pulmonary fibrosis / dizziness / drowsiness / tachycardia / dry mouth / NV / memory, concentration and confusion problems
- Can cause: excessive daytime somnolence, postural hypotension and visual hallucinations
- Usually used to delay the use of levodopa and then used in combination with levodopa to reduce the dose needed
- They increase impulsivity, shows as disinhibited behaviours i.e. gambling and hypersexuality
- g. pramipexole, ropinirole, bromocriptine
Monoamine oxidase B inhibitors
- These block the affects of monoamine oxidase B (an enzyme which breaks down dopamine)
- Used to delay the use of levodopa and used to reduce the required dose
- For example, Selegiline, Rasagiline